Search for: "Mylan Pharmaceuticals"
Results 81 - 100
of 738
Sort by Relevance
|
Sort by Date
24 Mar 2021, 3:09 am
This follows his 4 December 2020 judgment in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited [2020] EWHC 3270 (Pat) (the “Judgment”). [read post]
17 Mar 2021, 7:14 pm
Janssen Pharmaceuticals N.V., that this decision somehow forecloses the relief sought in the APA suit against the USPTO — not even close. [read post]
16 Mar 2021, 1:15 pm
In 2019, Janssen Pharmaceuticals sued Mylan Laboratories in district court for infringing U.S. [read post]
16 Mar 2021, 1:15 pm
In 2019, Janssen Pharmaceuticals sued Mylan Laboratories in district court for infringing U.S. [read post]
25 Jan 2021, 8:58 am
Mylan Pharmaceuticals. [read post]
22 Jan 2021, 10:31 am
One available use of the False Claims Act is to stop pharmaceutical manufacturers and pharmacy benefits managers (PBMs) from artificially inflating drug prices. [read post]
23 Dec 2020, 5:31 am
The starters (1) Interim injunction surprise In Neurim v Mylan [2020] EWHC 1362 (Pat), Marcus Smith J ruled on the claimants’ application for a prohibitory injunction. [read post]
22 Dec 2020, 7:15 am
Based on SPC FR08C0020, Gilead decided to take action for infringement against Mylan, which launched TENOFOVIR DISOPROXIL, a generic of TRUVADA®. [read post]
15 Dec 2020, 12:21 pm
Mylan Pharmaceuticals, Inc. [read post]
11 Dec 2020, 3:11 am
On 4 December 2020, the English Patents Court handed down its decision in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited, the main action proceedings regarding Neurim’s patent for Circadin, EP 1 441 702 (“EP 702”). [read post]
8 Dec 2020, 1:00 pm
[10] Gough, After Nearly 60 Years, Mylan Makes Way for Viatris, Pittsburg Bus. [read post]
17 Nov 2020, 9:16 pm
To almost finish a long post with a long sentence, one fact from that case: in view of the earlier cross-border case law that a Dutch MA holder also acts unlawful if a foreign entity, holding a pharmaceutical authorization, infringes with a generic product, Teva decided that the MA and pharmaceutical authorization should be held by the same entity within the group. [read post]
10 Nov 2020, 8:53 pm
Mylan... [read post]
10 Nov 2020, 4:15 am
Mylan Pharmaceuticals. [read post]
10 Nov 2020, 4:15 am
Mylan Pharmaceuticals. [read post]
10 Nov 2020, 2:01 am
Mylan Pharmaceuticals Inc. [read post]
8 Nov 2020, 9:37 am
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle | Invalidating a patent after expiry of the patent term? [read post]
6 Nov 2020, 7:16 am
Mylan Pharmaceuticals (Fed. [read post]
1 Nov 2020, 4:35 am
The District Court in the Hague made a ruling in the case between Novartis and Mylan, concerning the pharmaceutical Exjade, which is protected by both a patent and subsequently a Supplementary Protection Certificate as well by an Orphan Drug Designation. [read post]
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle
22 Oct 2020, 8:23 am
In cases where the relevant pharmaceutical does not have orphan drug status, the duration of the SPC is extended by six months, pursuant to Article 36. [read post]
